IKZF1 and precursor B-cell acute lymphoblastic leukemia: Given the shared ETS dependence across B-lineage malignancies and the elevated ERG expression and ETS-associated gene regulatory networks observed in IKZF1-deficient B-ALL, our findings support the potential utility of these agents in selectively targeting ETS-related vulnerabilities in this context.